U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis (Q77954417)
Jump to navigation
Jump to search
scientific article published on 01 January 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis |
scientific article published on 01 January 1999 |
Statements
U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis (English)